Brandywine Global Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Brandywine Global Investment Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-105,531	Closed	-$1.58M	–	786
2022 Q4	$1.58M	Hold	105,531	–	–	0.01%	593
2022 Q3	$869K	Sell	105,531 -3,869	-4%	-$29.7K	0.01%	633
2022 Q2	$718K	Sell	109,400 -16,500	-13%	-$79.9K	0.01%	636
2022 Q1	$704K	Hold	125,900	–	–	0.01%	641
2021 Q4	$590K	Sell	125,900 -3,600	-3%	-$22.3K	﹤0.01%	609
2021 Q3	$800K	Buy	+129,500	New	+$775K	0.01%	580

Brandywine Global Investment Management's AVEO Position: Q1 2023 in Review

Brandywine Global Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 105,531 shares — an estimated $1.58M sold.

Brandywine Global Investment Management first reported a position in AVEO in Q3 2021 and held it in 6 quarters. The position peaked at $1.58M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Brandywine Global Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Brandywine Global Investment Management sold 105,531 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.58M.
Brandywine Global Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2021 and held it in 6 quarters.
Brandywine Global Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $1.58M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Brandywine Global Investment Management's 13F filing for Q1 2023, filed 12 May 2023.